A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes
Clinical trial NCT04017832 · COMPLETED
Trial details
- NCT number
- NCT04017832
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-29
- Primary completion
- 2021-10-27
- Enrollment
- 1441
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.